Disparate effects of pramipexole on locomotor activity and sensorimotor gating in Sprague-Dawley rats

Pharmacology Biochemistry and Behavior

Volumn 99, Issue 4, 2011, Pages 634-638

  Chang, Wei Li ^a   Breier, Michelle R ^a   Yang, Alex ^a   Swerdlow, Neal R ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Dopamine; Locomotor activity; Pramipexole; Prepulse inhibition; Startle

Indexed keywords

DOPAMINE 2 RECEPTOR BLOCKING AGENT; L 741626; PRAMIPEXOLE; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ARTICLE; BEHAVIOR; CONTROLLED STUDY; DOSE RESPONSE; DRUG EFFECT; DRUG MECHANISM; LOCOMOTION; MALE; NONHUMAN; PREPULSE INHIBITION; PRIORITY JOURNAL; RAT; SENSORY GATING;

ANIMALS; BENZOTHIAZOLES; DATA INTERPRETATION, STATISTICAL; DOPAMINE AGONISTS; DOPAMINE ANTAGONISTS; DOSE-RESPONSE RELATIONSHIP, DRUG; INDOLES; MALE; MOTOR ACTIVITY; PIPERIDINES; RATS; RATS, SPRAGUE-DAWLEY; RECEPTORS, DOPAMINE D2; RECEPTORS, DOPAMINE D3; SENSORY GATING; STARTLE REACTION;

MUS; RATTUS;

EID: 79959710767     PISSN: 00913057     EISSN: 18735177     Source Type: Journal    
DOI: 10.1016/j.pbb.2011.06.002     Document Type: Article

References (41)

1. S. Ahlenius, and P. Salmi Behavioral and biochemical effects of the dopamine D3 receptor-selective ligand, 7-OH-DPAT, in the normal and the reserpine-treated rat Eur J Pharmacol 260 2-3 1994 177 181 (Pubitemid 24240019)
2. M.R. Breier, B. Lewis, J.M. Shoemaker, G.A. Light, and N.R. Swerdlow Sensory and sensorimotor gating-disruptive effects of apomorphine in Sprague Dawley and Long Evans rats Behav Brain Res 208 2 2010 560 565
3. S.B. Caine, M.A. Geyer, and N.R. Swerdlow Effects of D3/D2 dopamine receptor agonists and antagonists on prepulse inhibition of acoustic startle in the rat Neuropsychopharmacology 12 1995 139 145
4. H.K. Caldwell, S.L. Stephens, and W.S. Young III Oxytocin as a natural antipsychotic: a study using oxytocin knockout mice Mol Psychiatry 14 2009 190 196
5. W.L. Chang, M.A. Geyer, M.R. Buell, M. Weber, and N.R. Swerdlow The effects of pramipexole on prepulse inhibition and locomotor activity in C57BL/6J mice Behav Pharmacol 21 2010 135 143
6. W.L. Chang, N.R. Swerdlow, M.R. Breier, N. Thangaraj, and M. Weber Parametric approaches towards understanding the effects of the preferential D3 receptor agonist pramipexole on prepulse inhibition in rats Pharmacol Biochem Behav 95 2010 473 478
7. G.T. Collins, A.H. Newman, P. Grundt, K.C. Rice, S.M. Husbands, and C. Chauvignac Yawning and hypothermia in rats: effects of dopamine D3 and D2 agonists and antagonists Psychopharmacology (Berl) 193 2007 159 170 (Pubitemid 47025018)
8. P.J. Fray, B.J. Sahakian, T.W. Robbins, G.F. Koob, and S.D. Iversen An observational method for quantifying the behavioural effects of dopamine agonists: contrasting effects of d-amphetamine and apomorphine Psychopharmacology (Berl) 69 3 1980 253 259 (Pubitemid 10045691)
9. 3-preferring agonists 7-OH-PIPAT and PD128,907 on motor behaviors and place conditioning Behav Pharmacol 8 1997 65 74 (Pubitemid 27229660)
10. K. Kitagawa, Y. Kitamura, T. Miyazaki, J. Miyaoka, H. Kawasaki, and M. Asanuma Effects of pramipexole on the duration of immobility during the forced swim test in normal and ACTH-treated rats Naunyn Schmiedebergs Arch Pharmacol 380 2009 59 66
11. S. Kullback Information theory and statistics 1968 Dover New York
12. P. Lagos, C. Scorza, J.M. Monti, H. Jantos, M. Reyes-Parada, and R. Silveira Effects of the D3 preferring dopamine agonist pramipexole on sleep and waking, locomotor activity and striatal dopamine release in rats Eur Neuropsychopharmacol 8 2 1998 113 120 (Pubitemid 28210337)
13. J. Maj, Z. Rogoz, G. Skuza, and K. Kolodziejczyk The behavioural effects of pramipexole, a novel dopamine receptor agonist Eur J Pharmacol 324 1997 31 37 (Pubitemid 27160905)
14. S. Martin, M.A. Markus, B.J. Morris, R.L. Davisson, A.J. Lawrence, and M. van den Buuse Does angiotensin interact with dopaminergic mechanisms in the brain to modulate prepulse inhibition in mice? Neuropharmacology 54 2008 399 404
15. M.J. Millan, L. Seguin, A. Gobert, D. Cussac, and M. Brocco The role of dopamine D3 compared with D2 receptors in the control of locomotor activity: a combined behavioural and neurochemical analysis with novel, selective antagonists in rats Psychopharmacology (Berl) 174 3 2004 341 357 (Pubitemid 39044292)
16. 3-agonist PD 128907 J Pharmacol Exp Ther 275 1995 1355 1366 (Pubitemid 26130641)
17. R.J. Ralph, and S.B. Caine Effects of selective dopamine D1-like and D2-like agonists on prepulse inhibition of startle in inbred C3H/HeJ, SPRET/EiJ, and CAST/EiJ mice Psychopharmacology (Berl) 191 2007 731 739 (Pubitemid 46355880)
18. R.J. Ralph, G.B. Varty, M.A. Kelly, Y.M. Wang, M.G. Caron, and M. Rubinstein The dopamine D2, but not D3 or D4, receptor subtype is essential for the disruption of prepulse inhibition produced by amphetamine in mice J Neurosci 19 1999 4627 4633 (Pubitemid 29241110)
19. R.J. Ralph-Williams, V. Lehmann-Masten, V. Otero-Corchon, M.J. Low, and M.A. Geyer Differential effects of direct and indirect dopamine agonists on prepulse inhibition: a study in D1 and D2 receptor knock-out mice J Neurosci 22 2002 9604 9611 (Pubitemid 35356202)
20. R.J. Ralph-Williams, V. Lehmann-Masten, and M.A. Geyer Dopamine D1 rather than D2 receptor agonists disrupt prepulse inhibition of startle in mice Neuropsychopharmacology 28 2003 108 118
21. Richtand NM, Chang WL, Ahlbrand R, Swerdlow NR. The effects of pramipexole on locomotor activity in D3 mutant mice. Soc Neurosci in press.
22. T.W. Robbins A critique of the methods available for the measurement of spontaneous motor activity L. Iverson, S. Iversen, S. Snyder, Handbook of psychopharmacology vol. 7 1977 Plenum New York 37 82
23. H. Russig, W. Spooren, S. Durkin, J. Feldon, and B.K. Yee Apomorphine-induced disruption of prepulse inhibition that can be normalised by systemic haloperidol is insensitive to clozapine pretreatment Psychopharmacology (Berl) 175 2004 143 147 (Pubitemid 39222343)
24. S. Semenova, M.A. Geyer, J.G. Sutcliffe, A. Markou, and P.B. Hedlund Inactivation of the 5-HT(7) receptor partially blocks phencyclidine-induced disruption of prepulse inhibition Biol Psychiatry 63 2008 98 105 (Pubitemid 350234877)
25. P. Sokoloff, J. Diaz, B. Le Foll, O. Guillin, L. Leriche, and E. Bezard The dopamine D3 receptor: a therapeutic target for the treatment of neuropsychiatric disorders CNS Neurol Disord Drug Targets 5 2006 25 43 (Pubitemid 43796626)
26. K. Svensson, A. Carlsson, R.M. Huff, T. Kling-Petersen, and N. Waters Behavioral and neurochemical data suggest functional differences between dopamine D2 and D3 receptors Eur J Pharmacol 263 1994 235 243 (Pubitemid 24301301)
27. 3-ligand R-(+)-7-OH-DPAT is independent of changes in dopamine release J Neural Transm 95 1994 71 74
28. N.R. Swerdlow, R. Kuczenski, J.C. Goins, S.K. Crain, L.T. Ma, and M.J. Bongiovanni Neurochemical analysis of rat strain differences in the startle gating-disruptive effects of dopamine agonists Pharmacol Biochem Behav 80 2005 203 211 (Pubitemid 40170418)
29. N.R. Swerdlow, M. Breier, A.B. Mora, D. Ko, and J.M. Shoemaker A novel rat strain with enhanced sensitivity to the effects of dopamine agonists on startle gating Pharmacol Biochem Behav 88 3 2008 280 290 (Pubitemid 350116255)
30. N.R. Swerdlow, M. Weber, Y. Qu, G.A. Light, and D.L. Braff Realistic expectations of prepulse inhibition in translational models for schizophrenia research Psychopharmacology (Berl) 199 2008 331 388
31. N.R. Swerdlow, S.A. Lelham, A.N. Sutherland Owens, W.L. Chang, S.D.T. Sassen, and J.A. Talledo Pramipexole effects on startle gating in rats and normal men Psychopharmacology (Berl) 205 2009 689 698
32. M. van den Buuse, S. Martin, J. Brosda, K.J. Leck, K.I. Matthaei, and I. Hendry Enhanced effect of dopaminergic stimulation on prepulse inhibition in mice deficient in the alpha subunit of G(z) Psychopharmacology (Berl) 183 2005 358 367 (Pubitemid 41660422)
33. G.B. Varty, and G.A. Higgins Dopamine agonist-induced hypothermia and disruption of prepulse inhibition: evidence for a role of D3 receptors? Behav Pharmacol 9 1998 445 455
34. M. Weber, and N.R. Swerdlow Rat strain differences in startle gating-disruptive effects of apomorphine occur with both acoustic and visual prepulses Pharmacol Biochem Behav 88 2008 306 311 (Pubitemid 350116257)
35. M. Weber, W.L. Chang, M. Breier, D. Ko, and N.R. Swerdlow Heritable strain differences in sensitivity to the startle gating-disruptive effects of D2 but not D3 receptor stimulation Behav Pharmacol 19 2008 786 795
36. M. Weber, M. Breier, D. Ko, N. Thangaraj, D.E. Marzan, and N.R. Swerdlow Evaluating the antipsychotic profile of the preferential PDE10A inhibitor, papaverine Psychopharmacology (Berl) 203 4 2009 723 735
37. M. Weber, W.L. Chang, J.P. Durbin, P.E. Park, R.R. Luedtke, and R.H. Mach Using prepulse inhibition to detect functional D3 receptor antagonism: effects of WC10 and WC44 Pharmacol Biochem Behav 93 2009 141 147
38. M. Weber, W.L. Chang, M.R. Breier, E.J. Miller, N. Thangaraj, and A.C. Yang Pramipexole infusion into the nucleus accumbens disrupts prepulse inhibition in rats Biol Psychiatry 67 9 2010 73S
39. M. Weber, W.L. Chang, M.R. Breier, A. Yang, M.J. Millan, and N.R. Swerdlow The effects of the dopamine D2 agonist sumanirole on prepulse inhibition in rats Eur Neuropsychopharmacol 20 6 2010 421 425
40. B.K. Yee, H. Russig, and J. Feldon Apomorphine-induced prepulse inhibition disruption is associated with a paradoxical enhancement of prepulse stimulus reactivity Neuropsychopharmacology 29 2004 240 248 (Pubitemid 38175143)
41. M. Zhang, M.E. Ballard, L.V. Unger, A. Haupt, G. Gross, and M.W. Decker Effects of antipsychotics and selective D3 antagonists on PPI deficits induced by PD 128907 and apomorphine Behav Brain Res 182 2007 1 11 (Pubitemid 47042188)